News and Views
Recent Price Movement and Market Context
Vivanza Biosciences has experienced a notable decline in its share price over the past few days, with a consecutive three-day fall resulting in a cumulative loss of 6.49%. Despite a modest positive return of 5.88% over the last month, the stock has underperformed the broader Sensex index over the year and longer periods. Specifically, the stock has delivered a negative return of 38.46% over the past year, contrasting sharply with the Sensex’s positive 8.40% gain. Over three and five years, the disparity widens further, with Vivanza Biosciences declining by 86.58% and 82.97% respectively, while the Sensex has appreciated by 39.89% and 69.39% in the same periods.
On the day in question, the stock underperformed its sector by 3.28%...
Read full news article
